Can-Fite Completes Patient Enrollment in its Phase II/III Psoriasis Trial – Video




Can-Fite Completes Patient Enrollment in its Phase II/III Psoriasis Trial
PETACH TIKVA, Israel, June 17, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (CFBI.TA), a biotechnology company with a pipeline of proprietar...

By: CorporateProfile

See more here:
Can-Fite Completes Patient Enrollment in its Phase II/III Psoriasis Trial - Video

Related Posts

Comments are closed.